"COVID-19 does eliminate a significant number of T-cells, enough to make large numbers of sick people overwhelm emergency wards with RSV (respiratory syncytial virus), pneumonia, strep infections and other ailments."
https://www.therecor...2ef8cea80e.html
The study claims HIV is the only other infection capable of this. They're clear that COVID is nowhere as severe as HIV. But the loss of T-cells largely explains the rise in other infections we have been seeing.
Additional research supporting this concern:
T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
2022 Aug
https://pubmed.ncbi....h.gov/35567391/
"T-cell numbers and function recover in most patients after COVID-19. However, we find evidence of persistent T-cell activation up to 12 months after infection and describe a subgroup of severe COVID-19 patients with persistently low CD8+ T-cell counts exhibiting a dysregulated immune response during acute infection."
A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients
2021 Jul 19
https://pubmed.ncbi....h.gov/34288064/
Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients
17 March 2020
https://www.nature.c...1423-020-0401-3
"Recent studies have shown that in addition to dyspnea, hypoxemia, and acute respiratory distress, lymphopenia, and cytokine release syndrome are also important clinical features in patients with severe SARS-CoV-2 infection.3 This suggests that homeostasis of the immune system plays an important role in the development of COVID-19 pneumonia."
Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study
23 May 2021
https://www.mdpi.com...-4409/10/6/1293
SARS-CoV-2-induced immunodysregulation and the need for higher clinical suspicion for co-infection and secondary infection in COVID-19 patients
February 2021
https://www.scienced...684118220302140
"Currently, the pathogenic mechanisms underlying the SARS-CoV-2 infection associated with immune dysfunction that permits secondary infection are not well understood.... Co-infection prevalence is estimated to be as high as 50% among COVID-19 fatalities.9"